We currently do not have sufficient information about the CEO.
Key information
Justin Hanka
Chief executive officer
AU$98.2k
Total compensation
CEO salary percentage
n/a
CEO tenure
5.8yrs
CEO ownership
2.1%
Management average tenure
no data
Board average tenure
5.1yrs
Recent management updates
No updates
Recent updates
CEO Compensation Analysis
How has Justin Hanka's remuneration changed compared to MindBio Therapeutics's earnings?
Date
Total Compensation
Salary
Company Earnings
Mar 31 2026
n/a
n/a
-AU$7m
Dec 31 2025
n/a
n/a
-AU$6m
Sep 30 2025
n/a
n/a
-AU$4m
Jun 30 2025
AU$98k
n/a
-AU$3m
Mar 31 2025
n/a
n/a
-AU$2m
Dec 31 2024
n/a
n/a
-AU$608k
Sep 30 2024
n/a
n/a
-AU$269k
Jun 30 2024
AU$54k
AU$54k
-AU$411k
Compensation vs Market: Justin's total compensation ($USD68.65K) is below average for companies of similar size in the US market ($USD657.18K).
Compensation vs Earnings: Justin's compensation has increased whilst the company is unprofitable.
CEO
Justin Hanka (52 yo)
5.8yrs
Tenure
AU$98,162
Compensation
Mr. Justin Adam Hanka, B.Bus, Grad Dip. Fin, is Director of Americore Resources Corp. from July 13, 2026. He served as Non-Executive Director of Sparc AI Inc (formerly known as EYEFI Group Technologies Inc...
Board Members
Name
Position
Tenure
Compensation
Ownership
Justin Hanka
Co Founder
5.2yrs
AU$98.16k
2.09% $ 32.5k
Gavin Upiter
Independent Chairman
5.1yrs
AU$85.33k
no data
Zena Burgess
Independent Non Executive Director
5.1yrs
AU$85.33k
0.0046% $ 71.4
5.1yrs
Average Tenure
56yo
Average Age
Experienced Board: MBQI.F's board of directors are considered experienced (5.1 years average tenure).
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/07/23 23:32
End of Day Share Price
2026/07/21 00:00
Earnings
2026/03/31
Annual Earnings
2025/06/30
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
MindBio Therapeutics Corp. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.